hematoxylin has been researched along with fibrinogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, Y; Takahashi, M; Tezuka, T | 1 |
| Ge, JP; Gu, JP; He, J; Li, Y; Ma, K; Yin, YY | 1 |
2 other study(ies) available for hematoxylin and fibrinogen
| Article | Year |
|---|---|
Hematoxylin-stainability of keratohyalin granules is due to the novel component, fibrinogen γ-chain protein.
Topics: Antibodies, Monoclonal; Biomarkers; Cytoplasmic Granules; Dermatitis, Atopic; Dimerization; Fibrinogen; Fluorescent Antibody Technique, Indirect; Hematoxylin; Humans; Keratins; Peptide Fragments; Protein Binding; Sequence Analysis, Protein; Skin | 2010 |
The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways.
Topics: Animals; Anticoagulants; Catechin; Eosine Yellowish-(YS); Fibrinogen; Hematoxylin; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Polyphenols; Proto-Oncogene Proteins c-akt; Rabbits; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tea; Thrombin; Vascular Endothelial Growth Factor A; Venous Thrombosis; Warfarin | 2022 |